Introduction
Cone beam CT (CBCT) imaging is commonly used in radiotherapy (RT) for verification of patient and target position (Jaffray et al 2002 , McBain et al 2006 . Use of CBCT imaging can improve the quality of RT by reducing geometric errors, leading to the use of smaller margins, and providing potential for adaptive RT. However CBCT images often have poorly calibrated Hounsfield Units (HU) and are subject to artefacts and non-uniformity due to X-ray scatter, patient motion and detector persistence effects (Siewerdsen and Jaffray 2001, Marchant et al  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 2011 , Mail et al 2008 . As a result, tissue densities from CBCT are not suitable for use in heterogeneity-corrected re-calculation of RT delivered dose.
Several methods have been introduced to enable attenuation corrected RT dose calculations based on CBCT images. These include calibration of CBCT using HU-density curves derived from contrast phantom scans (Yang et al 2007, Guan and Dong 2009) or patient images (Fotina et al 2012 , Richter et al 2008 , scatter corrections (Zhu et al 2009 , Thing et al 2016 , Dunlop et al 2015 , uniformity corrections incorporating prior-information either in projection space (Niu et al 2010) or reconstructed image space (Fan et al 2015 , Marchant et al 2008 , and deformable image registration (DIR) with planning CT (pCT) (Veiga et al 2015 , Moteabbed et al 2015 .
Calibration of CBCT using a calibration curve derived from contrast phantom scans has been proposed (Yang et al 2007, Guan and Dong 2009) . Studies have been based on phantom images or a small number of patient images and have reported variable accuracy of dose calculations based on calibrated CBCT. Yang et al (2007) reported good dose calculation accuracy (< 2 %) for 3 prostate cases, but larger errors in 1 lung case (up to 5 %). Guan and Dong (2009) found CBCT-based dose calculation errors in a pelvic phantom of 2.5 %-6.7 % depending on the planning technique used.
CBCT calibration curves derived from regions of different tissue types in clinical images have also been proposed. Richter et al (2008) found dose errors less than 5 % using either patient specific or group-based calibration. Fotina et al (2012) reported a large spread of dose values using population based calibration. However both of these studies assessed accuracy of CBCT dose calculations by comparison to the planning CT dose distribution. Therefore they do not account for changes in anatomy between CT and CBCT acquisition. Zhu et al (2009) and Thing et al (2016) proposed CBCT scatter correction methods, but did not evaluate the effect on radiotherapy dose calculation accuracy. Dunlop et al (2015) found that dose calculations based on scatter corrected CBCT were acceptable for H&N images (errors up to 1.7 %) but less so for pelvis (errors up to 4.2 %) and lung (errors up to 8.0 %).
In DIR-based methods the planning CT is deformed to match the CBCT anatomy, allowing it to be used as the patient attenuation map for radiotherapy dose calculations. Use of DIR for CBCT-based dose assessment of RT is gaining popularity, with a number of commercial products recently incorporating this workflow. Studies of dose calculation accuracy using deformed CT have shown promising results, although based on small numbers of test images. Veiga et al (2015) used images from 5 head and neck (H&N) patients and found dose errors generally less than 2 %. Moteabbed et al (2015) found small errors (<1 %) in DIR-based CBCT dose calculations using images of a pelvic phantom. Detailed studies of CBCT-based dose calculation accuracy based on larger numbers of clinical images for a range of anatomical sites are still required.
We previously developed a prior-image based correction method to restore HU values and improve uniformity of CBCT images (Marchant et al 2008) (referred to here as the "shading correction"), which allows RT dose calculations based on corrected CBCT accurate to within 1-2 % .
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In this paper we compare the accuracy of CBCT-based RT dose assessment using either shading corrected CBCT images or deformable image registration. Our comparison includes two different open-source deformable image registration packages and is based on a large sample of clinical CBCT images at three different anatomical sites. Clinical images are used for the evaluation, rather than phantom images, in order to evaluate the effect of anatomical changes that occur between planning CT and CBCT acquisition, for example weight loss, development of atelectasis in the lung or changes in rectum/bladder filling. These changes may be quite large and have the potential to reduce the effectiveness of DIR. The shading correction uses prior information from the planning CT so it is also important to test its robustness to anatomical changes in the CBCT. We also introduce a method to assess the accuracy of RT dose metrics derived from CBCT dose calculations based on comparison to a density overridden version of the same image (see section section 2.4.3).
Methods

Cone beam CT images
CBCT images and RT plan data were collected for 44 patients undergoing RT (15 pelvis, 14 H&N, 15 lung) . Three CBCT images per patient were included in the study (132 CBCT images total). CBCT images were acquired by the Elekta XVI linac-integrated CBCT system (Elekta AB, Stockholm, Sweden), using XVI versions 4.5 or 5.0. The study was performed retrostpectively using only images acquired routinely as part of the patients' RT. All image and RT plan data was anonymized and ethical approval was obtained for inclusion in the study (UK REC ref. 15/LO/0146).
Shading correction algorithm
A previously reported "shading correction" algorithm was used to process the CBCT images to improve HU calibration and remove non-uniformity artifacts (Marchant et al 2008) . The algorithm uses the patient's planning CT image as prior information. Image histograms of the CBCT and pCT images are compared and a linear scaling is derived which best matches the main histogram peak positions (air and soft tissue) between the CBCT and pCT images . Next regions representing soft-tissue are identified in both images and other regions (e.g. air, lung, bone) are removed and filled by interpolation from surrounding soft-tissue areas. The CBCT image is then divided by the rigidly registered pCT image to create a "shading map" containing the relative brightness of each pixel in the CBCT image compared to the pCT. The shading map is smoothed so that it retains only low spatial frequency variations in brightness, and is then applied as a correction map for the CBCT image to produce the final corrected image. An example pelvis CBCT image is shown in Figure 1 before and after applying the shading correction. A c c e p t e d M a n u s c r i p t CT CBCT Corrected CBCT Figure 1 . Pelvis CT and CBCT images before and after application of the shading correction (all displayed with window level 0, width 500).
Deformable image registration
Deformable image registration was used to deform each patient's pCT to match the CBCT images for the same patient. DIR was done using two software packages: Elastix and Niftyreg. The algorithm parameters selected for each package were based on ones used in previous studies (see below) and while not systematically optimised with our data they were observed to produce good results in most of the test images. (Veiga et al 2014) . An initial rigid registration of pCT to CBCT was followed by DIR using the B-spline Free Form Deformation algorithm (Rueckert et al 1999 , Modat et al 2010 . The localized normalized cross-correlation (LNCC) similarity measure was used as this is able to account for spatial variation of CBCT pixel values by calculating similarity at each point over a local window (5 mm window size) (Veiga et al 2015) . A c c e p t e d M a n u s c r i p t 2.4. Assessment of dose calculation accuracy 2.4.1. Phantom study CT and CBCT images of the Alderson Rando phantom (RSD Inc, Long Beach, CA, USA) were used to test the accuracy of CBCT-based dose calculations. A five-field prostate IMRT plan and a Lung SBRT VMAT plan were created using using the Pinnacle RT planning system (v9.8, Philips Radiation Oncology Systems, Fitchburg, WI, USA) using representative target and organ at risk (OAR) volumes. Each plan was then copied onto co-registered CBCT images of the phantom before and after applying the shading correction. All beam parameters (including monitor units) were kept identical to the original plan. The dose was recalculated using heterogeneity correction based on the CBCT image values. Several dose metrics were evaluated for each CBCT dose calculation and compared to the original plan. The dose metrics compared were mean dose to planning target volume (PTV), dose covering 95 % of PTV, volume of rectum receiving greater than 40 Gy (prostate plan only) and maximum dose to spinal cord (lung plan only). Since the phantom does not deform between CT and CBCT images, the dose metric calculated from CBCT can be directly compared to the originally planned value.
Patient image study
All patient images (CBCT, corrected CBCT, and deformed CT) were imported to the Pinnacle RT planning system. RT dose distributions were re-calculated based on each patient's original RT plan and using CBCT image values for heterogeneity correction. Here CBCT could be either the raw CBCT, corrected CBCT, or deformed CT image. Table 1 shows further details of the treatment sites and techniques included in the study. CBCT images were included in the study only if the field of view (FOV) was sufficient to include the patient outline at all points where it is crossed by the RT beams. This ensures that RT dose can be calculated in all relevant areas. Most images acquired with Medium or Large FOV (41 cm or 50 cm diameter) satisfy this requirement. H&N patients are usually imaged with Small FOV (26 cm) which does not encompass the patient outline below the shoulders. Hence dose cannot be calculated based on the CBCT image in this region, without use of other methods to reconstruct the missing regions of the patient. For H&N patients in this study we evaluated only dose to the primary disease target volume, and did not consider dose to any nodal target volume that extended below the level of the shoulders.
Page 5 of 18 AUTHOR SUBMITTED MANUSCRIPT -PMB-106095 .R2   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t For each plan three clinically relevant dose metrics were calculated: mean dose to PTV, Dose covering 95% of PTV (D 95 ), and an OAR dose metric relevant to the target site: volume of rectum receiving greater than 40Gy (V 40Gy ) for pelvis plans, maximum dose to spinal cord (SC) for lung plans, and contralateral parotid mean dose for H&N plans. Pelvis and lung CBCT dose metrics were calculated based on PTV and OAR contours that had been propogated rigidly from pCT and then manually edited to account for any large changes between the images (e.g. to avoid contours extending beyond patient surface or into bone/air cavities). For H&N images the PTV and OAR contours were more commonly situated close to bone or the patient surface so were propogated from CT via DIR and visually inspected for anatomical plausibility.
2.4.3. Override ratio validation method For patient images there will be changes between CT and CBCT imaging, so the doses calculated from CBCT are not expected to be the same as the originally planned values. A method to test accuracy of CBCT dose calculations by comparison to a density overridden version of the same scan was developed and validated. This method was previously used in but is described here for completeness.
Because of anatomical changes between the pCT and CBCT images, it is expected that the dose metric calculated on CBCT will not be identical to that calculated on pCT. Instead the dose calculation is repeated after applying bulk density overrides to the image, and the ratio of the dose metric before and after applying the density override is calculated (the "override ratio"). It is expected that this ratio will remain constant for a particular patient and RT plan. This is because the error introduced by applying the density override depends mainly on the individual patient's tissue densities and each beam's path length through different tissues. These factors remain approximately constant for each patient/plan. Therefore the error in CBCT-based dose metrics can be revealed by comparing the CBCT override-ratio for each metric to that calculated from the pCT image (the gold standard). The density overrides that Page 6 of 18 AUTHOR SUBMITTED MANUSCRIPT -PMB-106095 .R2   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t were applied varied for each anatomical site. For pelvis images all tissue within the body contour was assigned density of 1 gcm -3 . For lung images the lung tissue was also assigned a uniform density based on that patient's mean lung HU. For H&N images, overrides were applied for soft-tissue, bone and air cavities within the patient. Figure 2 illustrates the procedure, where the override ratio for a dose metric calculated from CBCT, OR CBCT = (C/D), should be the same as that calculated from pCT, OR CT = (A/B). Any difference between the override ratio for CT and CBCT is attributed to the error in the CBCT dose calculation. Therefore the CBCT dose metric relative error is
The override-ratio method for determining accuracy of CBCT dose calculations was validated using 5 patients with repeat pCT (4 lung, 1 pelvis case). The override-ratio was calculated for target and OAR dose metrics for both pCT images for each patient, using the patient's original treatment plan. The assumption that the override-ratio remains constant for a particular patient, RT plan and dose metric could then be tested. Patients having repeat pCT tend to be those where large anatomical changes occur during RT. Hence this sample, while small, serves to test robustness of the override-ratio method to large changes between images. Figure 3 shows protate plan dose distributions calculated for planning CT, uncorrected CBCT, and shading corrected CBCT. Table 2 shows the PTV and rectum dose metrics calculated using each image, along with the error relative to planning CT for each of the CBCT images. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t
A
Results
Phantom study
Uncorrected CBCT results in large dose errors (+4.7 % for PTV, +24 % for rectum V40Gy). After shading correction all dose metric errors are much smaller (<2 %).
(a) (b) (c) Figure 4 shows lung plan dose distributions calculated for planning CT, uncorrected CBCT, and shading corrected CBCT. Table 3 shows the PTV and spinal cord dose metrics calculated using each image, along with the error relative to planning CT for each of the CBCT images. Uncorrected CBCT results in dose errors greater than 2 % for dose covering 95 % of PTV (D95) and spinal cord max dose. After shading correction all dose metric errors are reduced and are less than 2 %. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 
Image
PTV mean PTV D95 SC max (1cc) CT 6423 cGy 6001 cGy 590 cGy CBCT raw 6347 cGy (-1.2%) 5829 cGy (-2.9%) 615 cGy (+4.2%) CBCT shaded 6399 cGy (-0.4%) 5925 cGy (-1.3%) 588 cGy (-0.3%)
Validation of override-ratio method
For the five cases with repeat pCT, the differences between override-ratios calculated from the two CT images were small. Mean difference was 0.5 % with standard deviation 0.7 % (range -1.7 to +0.6 %). Figure 5a shows the distribution of differences in override-ratio between the two CT images. It should be noted that this validation included some cases showing quite large anatomical changes between the two pCT images. Figure 5b -c shows original and repeat pCT images for one of the lung cases with large change in lung volume and tumour size. Because of anatomical changes, the dose metrics tested were not always similar between the two images. Four out of five patients had at least one metric which differed by >3 % between the two images, and a maximum difference of 39 % was observed. The presence of these differences shows that override-ratio values obtained for two images of the same patient are consistent even if there are considerable anatomical changes between the images. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t
Deformable image registration performance
Both DIR algorithms performed well for the majority of images. Body surface and bone surfaces were usually well matched between deformed CT and CBCT. Soft tissue details were also well matched in regions where deformations were small or smooth. However, neither Elastix or Niftyreg was able to accurately reproduce large or complex changes such as large change in bladder filling, movement of small bowel loops or appearance/disappearance of gas pockets in the rectum. Figure 6 shows an example slice from a pelvis image where soft tissue deformations around the rectum and bladder are not accurately reproduced in the deformed CT. White arrows indicate regions where the deformed CT does not match the CBCT. Figure 7 shows example lung images for a case where the lung contour has changed markedly on the CBCT due to atelectasis. Neither DIR algorithm is able to reproduce this change, with Elastix (figure 7b) matching the reduced lung volume but introducing large deformations to the surrounding spine and rib bones, and Niftyreg (figure 7d) introducing less distortion to the surrounding anatomy but failing to accurately represent the reduced lung volume. Registration fails altogether for some CBCT images for both Elastix (3/132) and Niftyreg (6/132). This was always due to failure of the initial rigid registration step. Usually this happens for images where there is a large difference in FOV between the CT and CBCT so the default alignment of image centres does not produce a sufficient overlap between the images. In these cases manual adjustments to the registration parameters and/or the initial alignment position were required. Registration failures were easily recognised on visual inspection and appeared as obvious non-physical distortions of the deformed CT image.
Page 10 of 18 AUTHOR SUBMITTED MANUSCRIPT -PMB-106095 .R2   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t Figure 8 shows pelvis CBCT dose metric errors for raw CBCT, shading corrected CBCT and the two DIR algorithms. Raw CBCT shows the largest dose errors for all dose metrics with generally a large overestimation of dose and a large spread of errors. This is because the raw CBCT images have generally underestimated HU values, resulting in underestimated beam attenuation. Shading corrected CBCT images show much smaller dose metric errors, with mean error less than 0.25 % and standard deviation less than 0.6 %. No dose metrics had estimated errors greater than 2 %.
Pelvis images
Both DIR algorithms resulted in similar dose metric error results. The mean dose metric error is less than 0.25 % for all dose metrics studied for both Niftyreg and Elastix. Standard deviation of dose metric errors was also similar to shading corrected CBCT. This indicates that the soft-tissue mismatches in deformed CT noted in section section 3.3 do not give rise to large dose errors for pelvis images. However, both DIR algorithms led to a few images with dose metric error greater than 2% (2 for Niftyreg, 1 for Elastix). Figure 9 shows lung CBCT dose metric errors for raw CBCT, shading corrected CBCT and the two DIR algorithms. Raw CBCT results in the largest dose metric errors with mean error greater than 3% for all metrics and a large spread of errors.
Lung images
Shading corrected CBCT images have much smaller dose metric errors, with mean error less than 0.5 % and standard deviation of about 0.7 %. Dose metric error greater than 2 % was observed in only one case. Both DIR algorithms resulted in similar dose metric errors. The mean dose metric error was similar to shading corrected CBCT (less than 0.5 %), although the spread of errors was slightly larger than shading corrected CBCT (standard deivation about 1 %). Dose metric errors for deformed CT included more values greater than 2 % (10 cases for both deformable registration algorithms). The images giving rise to these larger errors include cases such as illustrated in figure 7 with large changes between CT and CBCT which are not correctly represented by the deformed CT. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 3.6. Head and neck images Figure 10 shows CBCT dose metric errors assessed for H&N patients for raw CBCT, shading corrected CBCT and the two DIR algorithms. Again the mean error and spread of errors is reduced for shading corrected CBCT and for both DIR algorithms. However for H&N images the errors for raw CBCT are already quite small, so the improvement is not as large as for pelvis or lung images. See section 4 for further discussion of this. Shading corrected CBCT and both DIR methods all showed similar performance in terms of dose metric errors with overall mean error of 0.1 % and standard deviation 0.4 %. No errors greater than 2 % were Page 13 of 18 AUTHOR SUBMITTED MANUSCRIPT -PMB-106095 .R2   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t observed for any of the methods. 
Discussion
The results presented here indicate that RT dose calculations based on CBCT images can be assessed with relatively small errors (generally <2 %) using any of the three methods tested (shading corrected CBCT, deformed CT with Elastix or Niftyreg). There is some evidence that the use of deformed CT leads to a larger spread of errors for lung and pelvis sites, with
Page 14 of 18 AUTHOR SUBMITTED MANUSCRIPT -PMB-106095 .R2   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t more cases where the dose metric error was greater than 2 %. This occurred in 1-2 % of cases for pelvis and 7 % of cases for lung. We attribute these larger errors for calculations based on defomed CT to discrepancies between the CBCT and deformed CT anatomy in areas where large or complex anatomical changes have occurred. It may be possible to improve the performance of deformable registration through further optimization of parameters, however trade-offs will be required and it is a significant challenge to find parameters that will work robustly in all situations. We found that manual adjustment of initial image alignment was necessary in a number of cases. Thus the DIR algorithms cannot be considered to be fully automatic and a degree of manual supervision will likely be required. In contrast the shading correction operated without user intervention for all of the test images used in this study.
Dose metric errors for raw H&N CBCT images (see figure 10 ) are generally smaller than those for raw pelvis or lung CBCT. This is explained firstly because the diameter of the head is smaller than either thorax or pelvis, causing fewer scattered X-rays with less severe scatter artefacts as a result. Secondly the majority of H&N images in our study were acquired with a newer version of the XVI software (v5.0) than for pelvis and lung images (mostly XVI v4.5). XVI v5.0 has improvements to calibration of CBCT Hounsfield Units, resulting in generally smaller dose metric errors, arguably good enough for clinical use without further correction. However there is still an improvement for shading corrected images or using DIR with pCT. This is because the changes in XVI v5.0 only improve the global normalization of the image, without correcting variations between different areas within the same image. It should also be noted that H&N CBCT images feature severe artefacts below the level of the shoulders, also present in XVI v5.0 images, which are reduced by the shading correction . The effect of these artefacts is not seen in the dose errors presented here because we did not analyse dose in regions of the image where the patient contour was outside the FOV.
A number of other studies haves evaluated the accuracy of CBCT dose calculations using either image correction or deformed CT as the basis for attenuation correction. Dunlop et al. (Dunlop et al 2015) assessed CBCT dose calculation accuracy using either density overrides applied to the CBCT or scatter-corrected CBCT reconstructions. pCT acquired on the same day as the CBCT was used as ground truth. Based on a study of 11 patients they observed dose metric errors up to 4.0 % for density override based methods. Scatter corrected CBCT was effective for H&N images (errors up to 1.7 %) but less so for pelvis (errors up to 4.2 %) and lung (errors up to 8.0 %).
Onozato et al. (Onozato et al 2014) studied CBCT dose calculation accuracy for 10 prostate patients using two HU modification schemes (histogram matching to pCT or multi-level threshold segmentation into air/fat/muscle/bone). DIR to pCT was used to allow direct comparison of CBCT-based dose metrics to those calculated from the pCT. Both HU modification schemes produced small dose metric differences (<2 %) compared to the pCT.
Veiga et al. (Veiga et al 2014) assessed CBCT dose calculations based on deformed CT using Niftyreg. The study uses 5 H&N patients (1 CBCT per patient) and assessed dose calculation accuracy by comparison to repeat pCT taken close in time to the CBCT. Dose difference of <2 % was found in 90 % of voxels within the body.
An notable feature of our study is the relatively large number of patients/images included 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t (132 CBCTs in total) . This is important because the dose metric errors typically form a normal distribution, which requires sufficient data points to get a good estimate of the width. With too little data we cannot reliably predict the frequency of large dose errors. A limitation of our study is that the true CBCT dose distribution is unknown, meaning that we had to approximate it using the override-ratio method described in section 2.4.3. Some uncertainty in the estimates of dose metric error remains (as illustrated by our validation study where errors up to 1.7 % were seen for patients with repeat CT imaging). Alternative validation methods have been used in other studies, e.g. comparison to CT image acquired on the same day (Dunlop et al 2015 , Veiga et al 2014 , or using DIR with pCT as ground truth (Onozato et al 2014) . However these alternatives are also subject to uncertainties. There will be differences between images acquired on the same day, either due to transient anatomical changes or differences in patient set-up position. DIR could not be used as ground-truth in our study as it was one of the techniques under assessment.
While shading corrected CBCT provided similar or better dose accuracy to deformed CT and superior robustness in our study, there are some advantages to use of DIR in RT practice. The ability to use deformation fields to propogate contours onto CBCT or for dose accumulation is important to enable adaptive RT. However, the accuracy and robustness of DIR required for these purposes is higher than needed to use deformed CT for attenuation correction of RT dose calculations. For example the deformation errors illustrated in figure 6 did not have a significant effect on the RT dose distribution calculated using this image. However if organ contours propogated to CBCT via the deformation field were used then large errors in the estimated dose metrics could still occur due to incorrect estimation of the organ position. It is still an open question whether current DIR algorithms are good enough to support these uses (Li et al 2017 , Schultheiss et al 2012 .
A further obstacle to use of CBCT for calculation of radiotherapy dose distributions is the limited FOV. The FOV may not encompass all areas of the body traversed by the radiotherapy beams. Hence it will not be possible to calculate delivered dose unless a method is available to replace areas outside of the FOV. Possible methods include merging of multiple CBCTs to extend the FOV (Ding et al 2007) , use of patient contour from rigidly registered pCT in areas outside the CBCT FOV (Dunlop et al 2015) , and use of deformable registration with pCT to estimate patient contour in areas outside the CBCT FOV (Veiga et al 2014) . In our study we only assessed dose in areas where the patient contour was fully within the CBCT FOV. Using medium or large FOV (41 cm or 50 cm diameter) this requirement was satisfied for the majority of pelvis and lung patients. Head and neck patients were usually imaged with small FOV (26 cm diameter), which was not large enough to cover the patient surface below the level of the shoulders. In these cases it may be necessary to image with larger FOV or to use one of the methods previously mentioned to replace the missing data.
Conclusion
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